ICH Q9(R1) Quality Risk Management Revision – Public Consultation

被引:0
|
作者
Pluta, Paul L.
机构
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 39 条
  • [1] Quality Quartets in Risk-Based Qualification: ICH Q9(R1) Considerations
    O’donnell, Kevin
    Campbell, Cliff
    Pharmaceutical Technology, 2023, 47 (08) : 32 - 36
  • [2] Navigating the Formality Spectrum in ICH Q9(R1)
    Haddad, Ghada
    Patel, Darshana
    Pharmaceutical Technology, 2023, 47 (07) : 40 - 45
  • [3] 新版ICH《Q9(R1):质量风险管理》解析
    吴菲
    胡菁
    高易娥
    孙营
    胡俊
    李茜
    中国食品药品监管, 2025, (02) : 62 - 69
  • [4] Application of ICH Q9 Quality Risk Management Tools for Advanced Development of Hot Melt Coated Multiparticulate Systems
    Stocker, Elena
    Becker, Karin
    Hate, Siddhi
    Hohl, Roland
    Schiemenz, Wolfgang
    Sacher, Stephan
    Zimmer, Andreas
    Salar-Behzadi, Sharareh
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (01) : 278 - 290
  • [5] GMP aspects in practice: The new ICH guidelines concerning quality: ICH Q8, Q9 and Q10
    Kirrstetter, R
    PHARMAZEUTISCHE INDUSTRIE, 2005, 67 (02): : 213 - 216
  • [6] The estimands framework: a primer on the ICH E9(R1) addendum
    Kahan, Brennan C.
    Hindley, Joanna
    Edwards, Mark
    Cro, Suzie
    Morris, Tim P.
    BMJ-BRITISH MEDICAL JOURNAL, 2024, 384
  • [7] PQLI Application of Science- and Risk-based Approaches (ICH Q8, Q9, and Q10) to Existing Products
    Chris Potter
    Journal of Pharmaceutical Innovation, 2009, 4 : 4 - 23
  • [8] PQLI Application of Science- and Risk-based Approaches (ICH Q8, Q9, and Q10) to Existing Products
    Potter, Chris
    JOURNAL OF PHARMACEUTICAL INNOVATION, 2009, 4 (01) : 4 - 23
  • [9] Application of estimand framework in ICH E9 (R1) to safety evaluation
    Wang, Xuelong
    Yang, Ping
    Yuan, Shuai S.
    Wang, William W. B.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2023, 33 (04) : 476 - 487
  • [10] Application of estimand framework in ICH E9 (R1) to vaccine trials
    Fu, Rong
    Li, Hal
    Wang, Xuelong
    Shou, Qiong
    Wang, William W. B.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2023, 33 (04) : 502 - 513